Optimizing methods and dodging pitfalls in microbiome research

Microbiome

Volumn 5, Issue 1, 2017, Pages

  Kim, Dorothy ^a   Hofstaedter, Casey E ^a   Zhao, Chunyu ^a   Mattei, Lisa ^a   Tanes, Ceylan ^a   Clarke, Erik ^b   Lauder, Abigail ^b   Sherrill Mix, Scott ^b   Chehoud, Christel ^b   Kelsen, Judith ^a   Conrad, Máire ^a   Collman, Ronald G ^c   Baldassano, Robert ^a   Bushman, Frederic D ^b   Bittinger, Kyle ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

16S rRNA gene; Best practices; Environmental contamination; Metagenomics; Methods; Shotgun metagenomics; Study design

Indexed keywords

ANTIBIOTIC AGENT; RNA 16S; TESTOSTERONE;

AGE; CLOSTRIDIUM DIFFICILE INFECTION; COMAMONADACEAE; CORYNEBACTERIUM; DIET; DNA EXTRACTION; FUNGUS GROWTH; GENE EXPRESSION; GENE SEQUENCE; GEOGRAPHY; HIGH THROUGHPUT SEQUENCING; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MICROBIAL BIOMASS; MICROBIAL CONTAMINATION; MICROBIOME; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; PROPIONIBACTERIUM; RALSTONIA; REVIEW; SEX; STATISTICAL ANALYSIS; STRUCTURAL GENE; TESTOSTERONE BLOOD LEVEL; ANIMAL; HUMAN; METAGENOMICS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROFLORA; PROCEDURES; REPRODUCIBILITY; STANDARDS;

ANIMALS; HUMANS; METAGENOMICS; MICROBIOLOGICAL TECHNIQUES; MICROBIOTA; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 85028357413     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/s40168-017-0267-5     Document Type: Review

References (129)

1. Chehoud C, Albenberg LG, Judge C, Hoffmann C, Grunberg S, Bittinger K, Wu GD. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1948-56. doi:10. 1097/MIB.0000000000000454.
2. Debelius JW, Vazquez-Baeza Y, McDonald D, Xu Z, Wolfe E, Knight R. Turning participatory microbiome research into usable data: lessons from the american gut project. J Microbiol Biol Educ. 2016;17(1):46-50. doi:10. 1128/jmbe.v17i1.1034.
3. Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, Huttenhower C. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol. 2012;8(7):e1002606. doi:10.1371/journal.pcbi.1002606.
4. Human Microbiome Project, C. A framework for human microbiome research. Nature. 2012;486(7402):215-21. doi:10.1038/nature11209.
5. Lewis JD, Chen EZ, Baldassano RN, Otley AR, Griffiths AM, Lee D, Bushman FD. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric crohn's disease. Cell Host Microbe. 2015;18(4):489-500. doi:10.1016/j.chom.2015.09.008.
6. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022-3. doi:10.1038/4441022a.
7. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65. doi:10.1038/nature08821.
8. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804-10. doi:10. 1038/nature06244.
9. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108(4):500-8. doi:10.1038/ajg.2013.59.
10. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Keller JJ. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407-15. doi:10.1056/NEJMoa1205037.
11. Baker GC, Smith JJ, Cowan DA. Review and re-analysis of domain-specific 16S primers. J Microbiol Methods. 2003;55(3):541-55.
12. D'Amore R, Ijaz UZ, Schirmer M, Kenny JG, Gregory R, Darby AC, Hall N. A comprehensive benchmarking study of protocols and sequencing platforms for 16S rRNA community profiling. BMC Genomics. 2016;17:55. doi:10.1186/ s12864-015-2194-9.
13. Liu Z, Lozupone C, Hamady M, Bushman FD, Knight R. Short pyrosequencing reads suffice for accurate microbial community analysis. Nucleic Acids Res. 2007;35(18):e120. doi:10.1093/nar/gkm541.
14. Mizrahi-Man O, Davenport ER, Gilad Y. Taxonomic classification of bacterial 16S rRNA genes using short sequencing reads: evaluation of effective study designs. PLoS One. 2013;8(1):e53608. doi:10.1371/journal.pone.0053608.
15. Schloss PD, Jenior ML, Koumpouras CC, Westcott SL, Highlander SK. Sequencing 16S rRNA gene fragments using the PacBio SMRT DNA sequencing system. PeerJ. 2016;4:e1869. doi:10.7717/peerj.1869.
16. Tremblay J, Singh K, Fern A, Kirton ES, He S, Woyke T, Tringe SG. Primer and platform effects on 16S rRNA tag sequencing. Front Microbiol. 2015;6:771. doi:10.3389/fmicb.2015.00771.
17. Aho VT, Pereira PA, Haahtela T, Pawankar R, Auvinen P, Koskinen K. The microbiome of the human lower airways: a next generation sequencing perspective. World Allergy Organ J. 2015;8(1):23. doi:10.1186/s40413-015-0074-z.
18. Bittinger K, Charlson ES, Loy E, Shirley DJ, Haas AR, Laughlin A, Bushman FD. Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing. Genome Biol. 2014; 15(10):487. doi:10.1186/s13059-014-0487-y.
19. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Collman RG. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184(8):957-63. doi:10.1164/ rccm.201104-0655OC.
20. Glassing A, Dowd SE, Galandiuk S, Davis B, Chiodini RJ. Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples. Gut Pathog. 2016;8:24. doi:10.1186/s13099-016-0103-7.
21. Jervis-Bardy J, Leong LE, Marri S, Smith RJ, Choo JM, Smith-Vaughan HC, Marsh RL. Deriving accurate microbiota profiles from human samples with low bacterial content through post-sequencing processing of Illumina MiSeq data. Microbiome. 2015;3:19. doi:10.1186/s40168-015-0083-8.
22. Lauder AP, Roche AM, Sherrill-Mix S, Bailey A, Laughlin AL, Bittinger K, Bushman FD. Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota. Microbiome. 2016;4(1):29. doi:10.1186/s40168-016-0172-3.
23. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Walker AW. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87. doi:10.1186/s12915-014-0087-z.
24. Weiss S, Amir A, Hyde ER, Metcalf JL, Song SJ, Knight R. Tracking down the sources of experimental contamination in microbiome studies. Genome Biol. 2014;15(12):564. doi:10.1186/s13059-014-0564-2.
25. Di Bella JM, Bao Y, Gloor GB, Burton JP, Reid G. High throughput sequencing methods and analysis for microbiome research. J Microbiol Methods. 2013;95(3):401-14. doi:10.1016/j.mimet.2013.08.011.
26. Foster JA, Bunge J, Gilbert JA, Moore JH. Measuring the microbiome: perspectives on advances in DNA-based techniques for exploring microbial life. Brief Bioinform. 2012;13(4):420-9. doi:10.1093/bib/bbr080.
27. Goodrich JK, Di Rienzi SC, Poole AC, Koren O, Walters WA, Caporaso JG, Ley RE. Conducting a microbiome study. Cell. 2014;158(2):250-62. doi:10.1016/j.cell.2014.06.037.
28. Kuczynski J, Lauber CL, Walters WA, Parfrey LW, Clemente JC, Gevers D, Knight R. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet. 2012;13(1):47-58. doi:10.1038/nrg3129.
29. Robinson CK, Brotman RM, Ravel J. Intricacies of assessing the human microbiome in epidemiologic studies. Ann Epidemiol. 2016;26(5):311-21. doi:10.1016/j.annepidem.2016.04.005.
30. Bikel S, Valdez-Lara A, Cornejo-Granados F, Rico K, Canizales-Quinteros S, Soberon X, Ochoa-Leyva A. Combining metagenomics, metatranscriptomics and viromics to explore novel microbial interactions: towards a systemslevel understanding of human microbiome. Comput Struct Biotechnol J. 2015;13:390-401. doi:10.1016/j.csbj.2015.06.001.
31. Kim Y, Koh I, Rho M. Deciphering the human microbiome using nextgeneration sequencing data and bioinformatics approaches. Methods. 2015; 79-80:52-9. doi:10.1016/j.ymeth.2014.10.022.
32. Laukens D, Brinkman BM, Raes J, De Vos M, Vandenabeele P. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol Rev. 2016;40(1):117-32. doi:10.1093/femsre/fuv036.
33. Tsilimigras MC, Fodor AA. Compositional data analysis of the microbiome: fundamentals, tools, and challenges. Ann Epidemiol. 2016;26(5):330-5. doi: 10.1016/j.annepidem.2016.03.002.
34. Kelly BJ, Gross R, Bittinger K, Sherrill-Mix S, Lewis JD, Collman RG, Li H. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics. 2015;31(15):2461-8. doi:10.1093/bioinformatics/btv183.
35. La Rosa PS, Brooks JP, Deych E, Boone EL, Edwards DJ, Wang Q, Shannon WD. Hypothesis testing and power calculations for taxonomic-based human microbiome data. PLoS One. 2012;7(12): e52078. doi:10.1371/journal.pone.0052078.
36. Blaser M, Bork P, Fraser C, Knight R, Wang J. The microbiome explored: recent insights and future challenges. Nat Rev Microbiol. 2013;11(3):213-7. doi:10.1038/nrmicro2973.
37. Dave M, Higgins PD, Middha S, Rioux KP. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res. 2012;160(4): 246-57. doi:10.1016/j.trsl.2012.05.003.
38. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415): 220-30. doi:10.1038/nature11550.
39. McKenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, Liu Z, Bushman FD. The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog. 2008;4(2):e20. doi:10.1371/journal.ppat.0040020.
40. Abeles SR, Ly M, Santiago-Rodriguez TM, Pride DT. Effects of long term antibiotic therapy on human oral and fecal viromes. PLoS One. 2015;10(8): e0134941. doi:10.1371/journal.pone.0134941.
41. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6(11):e280. doi:10.1371/journal.pbio.0060280.
42. Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010;5(3): e9836. doi:10.1371/journal.pone.0009836.
43. Devkota S. MICROBIOME. Prescription drugs obscure microbiome analyses. Science. 2016;351(6272):452-3. doi:10.1126/science.aaf1353.
44. Mardinoglu A, Boren J, Smith U. Confounding effects of metformin on the human gut microbiome in type 2 diabetes. Cell Metab. 2016;23(1):10-2. doi: 10.1016/j.cmet.2015.12.012.
45. Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, Zhernakova A. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740-8. doi:10.1136/gutjnl-2015-310376.
46. Amarasekara R, Jayasekara RW, Senanayake H, Dissanayake VH. Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia. J Obstet Gynaecol Res. 2015;41(5):662-9. doi:10.1111/jog.12619.
47. Dore J, Blottiere H. The influence of diet on the gut microbiota and its consequences for health. Curr Opin Biotechnol. 2015;32:195-9. doi:10. 1016/j.copbio.2015.01.002.
48. Fallucca F, Porrata C, Fallucca S, Pianesi M. Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet. Diabetes Metab Res Rev. 2014;30 Suppl 1:48-54. doi:10.1002/dmrr.2518.
49. Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskalova-Hogenova H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol. 2008;9:65. doi:10.1186/1471-2172-9-65.
50. Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr. 2012;108(5):801-9. doi:10. 1017/S0007114512001213.
51. Murphy EA, Velazquez KT, Herbert KM. Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr Opin Clin Nutr Metab Care. 2015;18(5):515-20. doi:10.1097/MCO.0000000000000209.
52. Rothe M, Blaut M. Evolution of the gut microbiota and the influence of diet. Benef Microbes. 2013;4(1):31-7. doi:10.3920/BM2012.0029.
53. Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH. The influence of diet on the gut microbiota. Pharmacol Res. 2013;69(1):52-60. doi:10.1016/j.phrs.2012.10.020.
54. Sherman MP, Zaghouani H, Niklas V. Gut microbiota, the immune system, and diet influence the neonatal gut-brain axis. Pediatr Res. 2015;77(1-2):127-35. doi:10.1038/pr.2014.161.
55. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Lewis JD. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105-8. doi:10.1126/science.1208344.
56. Wu GD, Compher C, Chen EZ, Smith SA, Shah RD, Bittinger K, Lewis JD. Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. Gut. 2016;65(1):63-72. doi:10.1136/gutjnl-2014-308209.
57. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559-63. doi:10.1038/nature12820.
58. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Ley RE. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4578-85. doi:10.1073/pnas.1000081107.
59. Lee D, Albenberg L, Compher C, Baldassano R, Piccoli D, Lewis JD, Wu GD. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology. 2015;148(6):1087-106. doi:10.1053/j.gastro.2015.01.007.
60. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Gordon JI. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222-7. doi:10.1038/nature11053.
61. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, O'Toole PW. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4586-91. doi:10.1073/pnas.1000097107.
62. Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28(8): 1221-38. doi:10.1210/me.2014-1108.
63. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle- Kampczyk U, Danska JS. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339(6123): 1084-8. doi:10.1126/science.1233521.
64. Davey KJ, O'Mahony SM, Schellekens H, O'Sullivan O, Bienenstock J, Cotter PD, Cryan JF. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacol (Berl). 2012;221(1):155-69. doi:10.1007/s00213-011-2555-2.
65. Liang X, Bushman FD, FitzGerald GA. Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock. Proc Natl Acad Sci U S A. 2015;112(33):10479-84. doi:10.1073/pnas.1501305112.
66. Ren W, Ma Y, Yang L, Gettie A, Salas J, Russell K, Cheng-Mayer C. Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial response. AIDS. 2015;29(10):F1-8. doi:10.1097/QAD.0000000000000711.
67. Noguera-Julian M, Rocafort M, Guillen Y, Rivera J, Casadella M, Nowak P, Paredes R. Gut microbiota linked to sexual preference and HIV infection. EBioMed. 2016;5:135-46. doi:10.1016/j.ebiom.2016.01.032.
68. Oh C, Lee K, Cheong Y, Lee SW, Park SY, Song CS, Lee JB. Comparison of the oral microbiomes of canines and their owners using next-generation sequencing. PLoS One. 2015;10(7):e0131468. doi:10.1371/journal.pone.0131468.
69. Song SJ, Lauber C, Costello EK, Lozupone CA, Humphrey G, Berg-Lyons D, Knight R. Cohabiting family members share microbiota with one another and with their dogs. Elife. 2013;2:e00458. doi:10.7554/eLife.00458.
70. Jalanka-Tuovinen J, Salonen A, Nikkila J, Immonen O, Kekkonen R, Lahti L, de Vos WM. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One. 2011;6(7):e23035. doi:10.1371/journal.pone.0023035.
71. Rajilic-Stojanovic M, Heilig HG, Tims S, Zoetendal EG, & de Vos WM. Longterm monitoring of the human intestinal microbiota composition. Environ Microbiol. 2012. doi:10.1111/1462-2920.12023
72. Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol. 1998;64(10):3854-9.
73. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W, Ren B, Xavier RJ. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15(3):382-92. doi:10.1016/j.chom.2014.02.005.
74. Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, Gravitt PE. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210(11):1723-33. doi:10. 1093/infdis/jiu330.
75. Chehoud C, Stieh DJ, Bailey AG, Laughlin AL, Allen SA, McCotter KL, Bushman FD. Associations of the vaginal microbiota with HIV infection, bacterial vaginosis and demographic factors. AIDS. 2017. doi:10.1097/QAD.0000000000001421.
76. Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, Ravel J. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012; 4(132):132ra152. doi:10.1126/scitranslmed.3003605.
77. Ravel J, Brotman RM, Gajer P, Ma B, Nandy M, Fadrosh DW, Forney LJ. Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome. 2013;1(1):29. doi:10.1186/2049-2618-1-29.
78. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Forney LJ. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4680-7. doi:10.1073/pnas.1002611107.
79. Liang X, Bushman FD, FitzGerald GA. Time in motion: the molecular clock meets the microbiome. Cell. 2014;159(3):469-70. doi:10.1016/j.cell.2014.10.020.
80. Thaiss CA, Zeevi D, Levy M, Segal E, Elinav E. A day in the life of the metaorganism: diurnal rhythms of the intestinal microbiome and its host. Gut Microbes. 2015;6(2):137-42. doi:10.1080/19490976.2015.1016690.
81. Bushon RN, Kephart CM, Koltun GF, Francy DS, Schaefer 3rd FW, Alan Lindquist HD. Statistical assessment of DNA extraction reagent lot variability in real-time quantitative PCR. Lett Appl Microbiol. 2010;50(3):276-82. doi:10. 1111/j.1472-765X.2009.02788.x.
82. Campbell JH, Foster CM, Vishnivetskaya T, Campbell AG, Yang ZK, Wymore A, Podar M. Host genetic and environmental effects on mouse intestinal microbiota. ISME J. 2012;6(11):2033-44. doi:10.1038/ismej.2012.54.
83. Hildebrand F, Nguyen TL, Brinkman B, Yunta RG, Cauwe B, Vandenabeele P, Raes J. Inflammation-associated enterotypes, host genotype, cage and interindividual effects drive gut microbiota variation in common laboratory mice. Genome Biol. 2013;14(1):R4. doi:10.1186/gb-2013-14-1-r4.
84. Arndt SS, Laarakker MC, van Lith HA, van der Staay FJ, Gieling E, Salomons AR, Ohl F. Individual housing of mice-impact on behaviour and stress responses. Physiol Behav. 2009;97(3-4):385-93. doi:10.1016/j.physbeh.2009.03.008.
85. Laber K, Veatch LM, Lopez MF, Mulligan JK, Lathers DM. Effects of housing density on weight gain, immune function, behavior, and plasma corticosterone concentrations in BALB/c and C57BL/6 mice. J Am Assoc Lab Anim Sci. 2008;47(2):16-23.
86. Paigen B, Currer JM, Svenson KL. Effects of varied housing density on a hybrid mouse strain followed for 20 months. PLoS One. 2016;11(2): e0149647. doi:10.1371/journal.pone.0149647.
87. Dollive S, Chen YY, Grunberg S, Bittinger K, Hoffmann C, Vandivier L, Bushman FD. Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment. PLoS One. 2013;8(8):e71806. doi:10.1371/journal. pone.0071806.
88. Wu GD, Lewis JD, Hoffmann C, Chen YY, Knight R, Bittinger K, Bushman FD. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol. 2010;10:206. doi:10.1186/1471-2180-10-206.
89. Song SJ, Amir A, Metcalf L, Amato KR, Xu ZZ, Humphrey G, & Knight R. Preservation methods differ in fecal microbiome stability, affecting suitability for field studies. mSystems. 2016; 1(3). doi:10.1128/mSystems.00021-16
90. Blekhman R, Tang K, Archie EA, Barreiro LB, Johnson ZP, Wilson ME, Tung J. Common methods for fecal sample storage in field studies yield consistent signatures of individual identity in microbiome sequencing data. Sci Rep. 2016;6:31519. doi:10.1038/srep31519.
91. Choo JM, Leong LE, Rogers GB. Sample storage conditions significantly influence faecal microbiome profiles. Sci Rep. 2015;5:16350. doi:10.1038/ srep16350.
92. Dominianni C, Wu J, Hayes RB, Ahn J. Comparison of methods for fecal microbiome biospecimen collection. BMC Microbiol. 2014;14:103. doi:10. 1186/1471-2180-14-103.
93. Hill CJ, Brown JR, Lynch DB, Jeffery IB, Ryan CA, Ross RP, O'Toole PW. Effect of room temperature transport vials on DNA quality and phylogenetic composition of faecal microbiota of elderly adults and infants. Microbiome. 2016;4(1):19. doi:10.1186/s40168-016-0164-3.
94. Kerckhof FM, Courtens EN, Geirnaert A, Hoefman S, Ho A, Vilchez-Vargas R, Boon N. Optimized cryopreservation of mixed microbial communities for conserved functionality and diversity. PLoS One. 2014;9(6):e99517. doi:10. 1371/journal.pone.0099517.
95. McKain N, Genc B, Snelling TJ, Wallace RJ. Differential recovery of bacterial and archaeal 16S rRNA genes from ruminal digesta in response to glycerol as cryoprotectant. J Microbiol Methods. 2013;95(3): 381-3. doi:10.1016/j.mimet.2013.10.009.
96. Sinha R, Abnet CC, White O, Knight R, Huttenhower C. The microbiome quality control project: baseline study design and future directions. Genome Biol. 2015;16:276. doi:10.1186/s13059-015-0841-8.
97. Vogtmann E, Chen J, Amir A, Shi J, Abnet CC, Nelson H, Sinha R. Comparison of collection methods for fecal samples in microbiome Studies. Am J Epidemiol. 2017;185(2):115-23. doi:10.1093/aje/kww177.
98. Luo T, Srinivasan U, Ramadugu K, Shedden KA, Neiswanger K, Trumble E, Foxman B. Effects of specimen collection methodologies and storage conditions on the short-term stability of oral microbiome taxonomy. Appl Environ Microbiol. 2016;82(18):5519-29. doi:10.1128/AEM.01132-16.
99. Lauber CL, Zhou N, Gordon JI, Knight R, Fierer N. Effect of storage conditions on the assessment of bacterial community structure in soil and human-associated samples. FEMS Microbiol Lett. 2010;307(1):80-6. doi:10. 1111/j.1574-6968.2010.01965.x.
100. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Kaczmarski EB, Fox AJ. Contamination and sensitivity issues with a real-time universal 16S rRNA PCR. J Clin Microbiol. 2000;38(5):1747-52.
101. Rand KH, Houck H. Taq polymerase contains bacterial DNA of unknown origin. Mol Cell Probes. 1990;4(6):445-50.
102. Tanner MA, Goebel BM, Dojka MA, Pace NR. Specific ribosomal DNA sequences from diverse environmental settings correlate with experimental contaminants. Appl Environ Microbiol. 1998;64(8):3110-3.
103. Shen H, Rogelj S, Kieft TL. Sensitive, real-time PCR detects low-levels of contamination by Legionella pneumophila in commercial reagents. Mol Cell Probes. 2006;20(3-4):147-53. doi:10.1016/j.mcp. 2005.09.007.
104. Kennedy K, Hall MW, Lynch MD, Moreno-Hagelsieb G, Neufeld JD. Evaluating bias of illumina-based bacterial 16S rRNA gene profiles. Appl Environ Microbiol. 2014;80(18):5717-22. doi:10.1128/AEM.01451-14.
105. Wagner Mackenzie B, Waite DW, Taylor MW. Evaluating variation in human gut microbiota profiles due to DNA extraction method and inter-subject differences. Front Microbiol. 2015;6:130. doi:10.3389/fmicb.2015.00130.
106. Lazarevic V, Gaia N, Girard M, Schrenzel J. Decontamination of 16S rRNA gene amplicon sequence datasets based on bacterial load assessment by qPCR. BMC Microbiol. 2016;16:73. doi:10.1186/s12866-016-0689-4.
107. Knights D, Kuczynski J, Charlson ES, Zaneveld J, Mozer MC, Collman RG, Kelley ST. Bayesian community-wide culture-independent microbial source tracking. Nat Methods. 2011;8(9):761-3. doi:10.1038/nmeth.1650.
108. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6(237):237ra265. doi:10. 1126/scitranslmed.3008599.
109. Antony KM, Ma J, Mitchell KB, Racusin DA, Versalovic J, Aagaard K. The preterm placental microbiome varies in association with excess maternal gestational weight gain. Am J Obstet Gynecol. 2015;212(5):653. doi:10.1016/ j.ajog.2014.12.041. e651-616.
110. Zheng J, Xiao X, Zhang Q, Mao L, Yu M, Xu J. The placental microbiome varies in association with low birth weight in full-term neonates. Nutrients. 2015;7(8):6924-37. doi:10.3390/nu7085315.
111. Yuan S, Cohen DB, Ravel J, Abdo Z, Forney LJ. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS One. 2012;7(3):e33865. doi:10.1371/journal.pone.0033865.
112. Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, Birren BW. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21(3):494-504. doi:10.1101/gr.112730.110.
113. Parada AE, Needham DM, Fuhrman JA. Every base matters: assessing small subunit rRNA primers for marine microbiomes with mock communities, time series and global field samples. Environ Microbiol. 2016;18(5):1403-14. doi:10.1111/1462-2920.13023.
114. Kircher M, Heyn P, Kelso J. Addressing challenges in the production and analysis of illumina sequencing data. BMC Genomics. 2011;12:382. doi:10. 1186/1471-2164-12-382.
115. Brady T, Roth SL, Malani N, Wang GP, Berry CC, Leboulch P, Bushman FD. A method to sequence and quantify DNA integration for monitoring outcome in gene therapy. Nucleic Acids Res. 2011;39(11):e72. doi:10.1093/nar/gkr140.
116. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4516-22. doi:10.1073/pnas.1000080107.
117. Walters W, Hyde ER, Berg-Lyons D, Ackermann G, Humphrey G, Parada A, Knight R. Improved bacterial 16S rRNA gene (V4 and V4-5) and fungal internal transcribed spacer marker gene primers for microbial community surveys. mSystems. 2016; 1(1). doi:10.1128/mSystems.00009-15.
118. Laurence M, Hatzis C, Brash DE. Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes. PLoS One. 2014;9(5):e97876. doi:10.1371/journal.pone.0097876.
119. Bhatt AS, Freeman SS, Herrera AF, Pedamallu CS, Gevers D, Duke F, Meyerson M. Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013;369(6):517-28. doi:10.1056/NEJMoa1211115.
120. Dunn O. Multiple Comparisons Among Means. J Am Stat Assoc. 1961; 56(293):52-64. doi:10.2307/2282330. citeulike-article-id:7471132.
121. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289-300. doi:10.2307/2346101. citeulike-article-id:1042553.
122. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335-6. doi:10.1038/nmeth.f.303.
123. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Weber CF. Introducing mothur: open-source, platform-independent, communitysupported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537-41. doi:10.1128/AEM.01541-09.
124. Wang X, Tucker NR, Rizki G, Mills R, Krijger PH, de Wit E, Boyer LA. Discovery and validation of sub-threshold genome-wide association study loci using epigenomic signatures. Elife. 2016; 5. doi:10.7554/eLife.10557
125. Sabino J, Vieira-Silva S, Machiels K, Joossens M, Falony G, Ballet V, Raes J. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut. 2016. doi:10.1136/gutjnl-2015-311004
126. Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Pedersen O. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528(7581):262-6. doi:10.1038/nature15766.
127. Shaw KA, Bertha M, Hofmekler T, Chopra P, Vatanen T, Srivatsa A, Kugathasan S. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med. 2016;8(1):75. doi:10.1186/s13073-016-0331-y.
128. Kelsen J, Bittinger K, Pauly-Hubbard H, Posivak L, Grunberg S, Baldassano R, Bushman FD. Alterations of the subgingival microbiota in pediatric Crohn's disease studied longitudinally in discovery and validation cohorts. Inflamm Bowel Dis. 2015;21(12):2797-805. doi:10.1097/MIB.0000000000000557.
129. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71(12):8228-35. doi:10. 1128/AEM.71.12.8228-8235.2005.